Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,2307172,Activ4,Activity QTL 4,3.71,0.00023,locomotor behavior trait (VT:0001392),number of entries into a discrete space in an experimental apparatus (CMO:0000960),16,1,34465490,Rat,n/a,region,qtl 1000,737826,Alc11,Alcohol consumption QTL 11,3.2,,consumption behavior trait (VT:0002069),ethanol drink intake rate (CMO:0001407),16,5013802,64012784,Rat,n/a,region,qtl 1000,631830,Alc7,Alcohol consumption QTL 7,2.9,,consumption behavior trait (VT:0002069),ethanol drink intake rate (CMO:0001407),16,1,27556253,Rat,n/a,region,qtl 1000,1600378,Arunc4,Aerobic running capacity QTL 4,,0.03,exercise endurance trait (VT:0002332),maximum distance run on treadmill (CMO:0001406),16,1090054,86162972,Rat,n/a,region,qtl 1000,61338,Bp23,Blood pressure QTL 23,4.3,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),16,5013802,50013802,Rat,n/a,region,qtl 1000,2306902,Bp339,Blood pressure QTL 339,,0.01,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),16,4136355,45905331,Rat,n/a,region,qtl 1000,61372,Bp40,Blood pressure QTL 40,2.2,,blood pressure trait (VT:0000183),systolic blood pressure (CMO:0000004),16,5098704,19398181,Rat,n/a,region,qtl 1000,70183,BpQTLcluster13,Blood pressure QTL cluster 13,3.654,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),16,5013802,45905331,Rat,n/a,region,qtl 1000,70183,BpQTLcluster13,Blood pressure QTL cluster 13,3.654,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),16,5013802,45905331,Rat,n/a,region,qtl 1000,70183,BpQTLcluster13,Blood pressure QTL cluster 13,3.654,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),16,5013802,45905331,Rat,n/a,region,qtl 1000,6903319,Bw114,Body weight QTL 114,2.7,0.0037,body mass (VT:0001259),body weight (CMO:0000012),16,244593,45244593,Rat,n/a,region,qtl 1000,2303566,Bw90,Body weight QTL 90,2,,body mass (VT:0001259),body weight (CMO:0000012),16,1,41240937,Rat,n/a,region,qtl 1000,2312660,Bw95,Body weight QTL 95,,0.05,inguinal fat pad mass (VT:0010424),inguinal fat pad weight to body weight ratio (CMO:0001253),16,1550187,63210301,Rat,n/a,region,qtl 1000,1354584,Despr6,Despair related QTL 6,3.1,0.0067,locomotor behavior trait (VT:0001392),amount of time spent in voluntary immobility (CMO:0001043),16,1,41240937,Rat,n/a,region,qtl 1000,1354625,Despr7,Despair related QTL 7,3.16,0.016,locomotor behavior trait (VT:0001392),amount of time spent in voluntary immobility (CMO:0001043),16,1728297,46728297,Rat,n/a,region,qtl 1000,7411664,Foco30,Food consumption QTL 30,11,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),16,1340741,46340741,Rat,n/a,region,qtl 1000,2293343,Glom16,Glomerulus QTL 16,7.4,,kidney glomerulus integrity trait (VT:0010546),kidney sclerotic glomeruli count to total glomeruli count ratio (CMO:0001269),16,1550187,49247447,Rat,n/a,region,qtl 1000,737819,Hcas4,Hepatocarcinoma susceptibility QTL 4,4.43,,liver integrity trait (VT:0010547),volume of individual liver tumorous lesion (CMO:0001078),16,5013802,50169318,Rat,n/a,region,qtl 1000,1600369,Hcas8,Hepatocarcinoma susceptibility QTL 8,,,liver integrity trait (VT:0010547),liver tumorous lesion number (CMO:0001068),16,1,24228366,Rat,n/a,region,qtl 1000,631561,Hcuc2,Hepatic copper content QTL 2,2.8,,hepatic copper amount (VT:0003065),liver total copper weight (CMO:0001507),16,1,41240957,Rat,n/a,region,qtl 1000,2312666,Insul16,Insulin level QTL 16,,0.01,blood insulin amount (VT:0001560),serum insulin level (CMO:0000358),16,1550187,63210301,Rat,n/a,region,qtl 1000,1582235,Insul8,Insulin level QTL 8,3.3,0.0063,blood insulin amount (VT:0001560),calculated serum insulin level (CMO:0000359),16,1,27556253,Rat,n/a,region,qtl 1000,61405,Niddm6,Non-insulin dependent diabetes mellitus QTL 6,3.66,0.001,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),16,5013802,52144919,Rat,n/a,region,qtl 1000,634355,Rends4,Renal damage susceptibility QTL 4,,0.05,kidney blood vessel morphology trait (VT:0000530),organ lesion measurement (CMO:0000677),16,1,27556253,Rat,n/a,region,qtl 1000,1300133,Rf24,Renal function QTL 24,3.64,,blood creatinine amount (VT:0005328),creatinine clearance (CMO:0000765),16,4136355,23105837,Rat,n/a,region,qtl 1000,631517,Scl9,Serum cholesterol level QTL 9,3.3,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),16,17309396,22744540,Rat,n/a,region,qtl 1000,9590151,Scort8,Serum corticosterone level QTL 8,8.45,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),16,1,31816439,Rat,n/a,region,qtl 1000,2302380,Slep6,Serum leptin concentration QTL 6,3.36,,blood leptin amount (VT:0005667),serum leptin level (CMO:0000780),16,1,33160624,Rat,n/a,region,qtl 1000,2312663,Slep9,Serum leptin concentration QTL 9,,0.001,blood leptin amount (VT:0005667),serum leptin level (CMO:0000780),16,1550187,63210301,Rat,n/a,region,qtl 1000,2312669,Stl23,Serum triglyceride level QTL 23,,0.01,blood triglyceride amount (VT:0002644),serum triglyceride level (CMO:0000360),16,1550187,63210301,Rat,n/a,region,qtl